Abstract Coronavirus disease 2019 (COVID-19), with a high prevalence rate, has rapidly
infected millions of people around the world. Since viral infections can disrupt the …

Evidence of micro-and macro-thrombi in the arteries and veins of critically ill COVID-19
patients and in autopsies highlight the occurrence of COVID-19-associated coagulopathy …

Background Extracorporeal membrane oxygenation (ECMO) represents an advanced option
for supporting refractory respiratory and/or cardiac failure. Systemic anticoagulation with …

An outbreak of the novel coronavirus SARS-CoV-2, the causative agent of Coronavirus
Disease-2019 (COVID-19), a respiratory disease, has infected almost one hundred million …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting
coronavirus disease 2019 (COVID-19) represented a global public health crisis and the …

Purpose COVID-19 strangely kills some youth with no history of physical weakness, and in
addition to the lungs, it may even directly harm other organs. Its complex mechanism has led …

Identifying drug targets mitigating vascular dysfunction, thrombo‐inflammation and
thromboembolic complications in COVID‐19 is essential. COVID‐19 coagulopathy differs …

Background Unfractionated heparin sodium and nafamostat mesylate have long been used
as anticoagulants in continuous kidney replacement therapy (CKRT) where citrate is …

Given the limited information on the coagulation abnormalities of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) in pediatric patients, we designed a systematic …

The complement system (CS) plays a pivotal role in Coronavirus disease 2019 (COVID-19)
pathophysiology. The objective of this study was to provide a comparative, prospective data …